We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




New Optical Clearing Method Preserves Critical Brain Tissue Structures

By LabMedica International staff writers
Posted on 30 Sep 2015
Print article
Image: A three-dimensional visualization of A-beta plaques (green) and blood vessels (red) in a region of cerebral cortex from a 20-month-old Alzheimer\'s disease model mouse (Photo courtesy of RIKEN Brain Science Institute).
Image: A three-dimensional visualization of A-beta plaques (green) and blood vessels (red) in a region of cerebral cortex from a 20-month-old Alzheimer\'s disease model mouse (Photo courtesy of RIKEN Brain Science Institute).
A recent paper described the use of a sorbitol-based optical clearing method that provides stable tissue preservation for immunochemical labeling and three-dimensional signal rendering.

Existing tissue clearing reagents contain chemical components that can compromise tissue structure, preventing reproducible anatomical and fluorescence signal stability.

To avoid tissue damage from the clearing reagent, investigators at the RIKEN Brain Science Institute (Saitama, Japan) spent the last five years improving their urea-based Scale clearing reagent. The result, the sorbitol-based ScaleS reagent, was used to prepare tissues from the brains of mice with a genetic model of Alzheimer's disease.

Results published in the September 14, 2015, online edition of the journal Nature Neuroscience revealed that comparative benchmarking of contemporary clearing agents showed that ScaleS provided superior signal and structural preservation. ScaleS permitted optical reconstructions of aged and diseased brain in Alzheimer's disease models, including mapping of three-dimensional networks of amyloid plaques, neurons, and microglia, and multiscale tracking of single plaques by successive fluorescence and electron microscopy.

"The key ingredient of our new formula is sorbitol, a common sugar alcohol," said senior author Dr. Atsushi Miyawaki, senior team leader in cell function dynamics at the RIKEN Brain Science Institute. "By combining sorbitol in the right proportion with urea, we could create transparent brains with minimal tissue damage, that can handle both fluorescent and immunohistochemical labeling techniques, and is even effective in older animals."

"Clearing tissue with ScaleS followed by three-dimensional microscopy has clear advantages over two-dimensional stereology or immunohistochemistry," said Dr. Miyawaki. "Our technique will be useful not only for visualizing plaques in Alzheimer's disease, but also for examining normal neural circuits and pinpointing structural changes that characterize other brain diseases."

Related Links:

RIKEN Brain Science Institute


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.